Tyra Biosciences, Inc. · NASDAQ:TYRA

Dapice Joshua J. reported a 6.60% stake in Tyra Biosciences, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 12, 2026

Dapice Joshua J. reported a 6.60% stake in Tyra Biosciences, Inc., 3,580,818 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G/A).

Stake
6.60%
Shares
3,580,818
Intent
Passive
What changed
Stake changed
Filed together
28 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.1.10%579,376
Farallon Capital Institutional Partners, L.P.1.40%739,107
Farallon Capital Institutional Partners II, L.P.0.20%121,341
Farallon Capital Institutional Partners III, L.P.0.20%105,941
Four Crossings Institutional Partners V, L.P.0.20%126,343
Farallon Capital Offshore Investors II, L.P.2.70%1,452,596
Farallon Capital (AM) Investors, L.P.0.10%74,008
Farallon Capital F5 Master I, L.P.0.30%173,106
Farallon Healthcare Partners Master, L.P.0.40%209,000
Farallon Partners, L.L.C.6.30%3,407,712
Farallon Institutional (GP) V, L.L.C.0.20%126,343
Farallon F5 (GP), L.L.C.0.30%173,106
Farallon Healthcare Partners (GP), L.L.C.0.40%209,000
Dapice Joshua J.6.60%3,580,818
Dreyfuss, Philip D.6.60%3,580,818
Dunn Hannah E.6.60%3,580,818
Gehani, Varun N.6.60%3,580,818
Giauque, Nicolas6.60%3,580,818
Husen, Avner A.6.60%3,580,818
Kim, David T.6.60%3,580,818
Linn, Michael G.6.60%3,580,818
Luo Patrick (Cheng)6.60%3,580,818
Roberts, Jr., Thomas G.6.60%3,580,818
Saito Edric C.6.60%3,580,818
Short Daniel S.6.60%3,580,818
Spokes, Andrew J. M.6.60%3,580,818
Warren, John R.6.60%3,580,818
Wehrly, Mark C.6.60%3,580,818

Source

View original at SEC

Related